SEC 13F Intelligence

Folger Nolan Fleming Douglas Capital Management, Inc / JNJ

Folger Nolan Fleming Douglas Capital Management, Inc’s Johnson & Johnson Position

Does Folger Nolan Fleming Douglas Capital Management, Inc own Johnson & Johnson (JNJ)? Yes — 103.2K shares worth $26M (+2.14% of its 13F portfolio) as of Q2 2026, down from 104.0K shares the prior filed quarter.

Position Value
$26M
Q2 2026
Shares
103.2K
% of Portfolio
+2.14%
Quarters Held
31
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $15MQ4 ’18Q1 ’19: $16MQ2 ’19: $16MQ3 ’19: $14MQ4 ’19: $16MQ4 ’19Q1 ’20: $14MQ2 ’20: $15MQ3 ’20: $16MQ4 ’20: $17MQ4 ’20Q1 ’21: $17MQ2 ’21: $17MQ3 ’21: $17MQ4 ’21: $18MQ4 ’21Q1 ’22: $19MQ2 ’22: $19MQ3 ’22: $18MQ4 ’22: $19MQ4 ’22Q1 ’23: $17MQ2 ’23: $18MQ3 ’23: $17MQ4 ’23: $17MQ4 ’23Q1 ’24: $17MQ2 ’24: $16MQ3 ’24: $17MQ4 ’24: $15MQ4 ’24Q1 ’25: $17MQ2 ’25: $15MQ3 ’25: $19MQ4 ’25: $21MQ4 ’25Q1 ’26: $25MQ2 ’26: $26Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026103.2K$26M+2.14%
Q1 2026104.0K$25M+2.27%
Q4 2025100.2K$21M+2.13%
Q3 2025100.5K$19M+1.95%
Q2 2025101.2K$15M+1.71%
Q1 2025102.3K$17M+1.91%
Q4 2024103.7K$15M+1.57%
Q3 2024105.8K$17M+1.69%
Q2 2024107.2K$16M+1.60%
Q1 2024106.8K$17M+1.72%
Q4 2023106.7K$17M+1.82%
Q3 2023108.1K$17M+1.96%
Q2 2023108.8K$18M+1.96%
Q1 2023107.4K$17M+1.94%
Q4 2022108.7K$19M+2.32%
Q3 2022107.5K$18M+2.39%
Q2 2022106.5K$19M+2.48%
Q1 2022107.1K$19M+2.12%
Q4 2021107.0K$18M+1.99%
Q3 2021106.3K$17M+2.06%
Q2 2021104.5K$17M+1.99%
Q1 2021105.8K$17M+2.11%
Q4 2020105.0K$17M+2.18%
Q3 2020106.0K$16M+2.36%
Q2 2020105.1K$15M+2.40%
Q1 2020105.8K$14M+2.77%
Q4 2019107.6K$16M+2.29%
Q3 2019108.9K$14M+2.18%
Q2 2019113.3K$16M+2.36%
Q1 2019113.7K$16M+2.38%
Q4 2018114.4K$15M+2.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Folger Nolan Fleming Douglas Capital Management, Inc’s full portfolio or all institutional holders of JNJ.